Hayfever Relief (Sodium Cromoglicate)

Hayfever Relief is indicated for the management of ocular allergic conditions that are associated with hay fever and seasonal allergens.

• Allergic conjunctivitis caused by seasonal pollen exposure.
• Ocular symptoms of hay fever such as itching, redness, and tearing.
• Mild to moderate allergic eye irritation due to dust or animal dander.
• Prevention of mast‑cell degranulation in the conjunctiva to reduce inflammatory response.
• Adjunctive therapy for patients using antihistamine eye drops who need additional mast‑cell stabilization.
• Use as part of a comprehensive allergy management plan to reduce reliance on oral antihistamines.

The safety profile of Hayfever Relief reflects its local ocular administration, with most reported events being mild and transient.

Common

• Temporary eye irritation or burning sensation after instillation.
• Mild blurred vision that resolves within minutes.
• Slight eye redness or watery discharge.
• Minor headache unrelated to systemic absorption.
• Temporary sensation of dryness after use.
• Transient mild conjunctival swelling that resolves without treatment.

Serious

• Persistent eye pain or worsening redness.
• Signs of allergic reaction such as swelling of the eyelids.
• Development of corneal ulceration.
• Severe visual disturbance requiring medical attention.
• Development of allergic contact dermatitis around the eye.
• Sudden loss of vision or sudden increase in intra‑ocular pressure.

Before using Hayfever Relief, certain precautions should be considered to ensure safe and effective use.

• Do not use if you have a known hypersensitivity to sodium cromoglicate or any excipients.
• Avoid contact lens wear for at least 15 minutes after each dose.
• Consult an eye‑care professional if symptoms persist beyond a week.
• Use with caution in patients with pre‑existing ocular infections or inflammation.
• Pregnant or breastfeeding individuals should seek medical advice before initiating therapy.
• Keep the container tightly closed and store at room temperature away from direct sunlight.
• Do not share the eye‑drop bottle with other individuals to avoid cross‑contamination.

Hayfever Relief may interact with other ophthalmic products, and certain combinations should be avoided or monitored.

Avoid

• Concurrent use of other mast‑cell stabilizer eye drops without professional guidance.
• Simultaneous administration of preservative‑containing eye solutions that may increase irritation.
• Using eye drops containing high concentrations of preservatives concurrently, which may increase ocular irritation.

Use with caution

• Combining with topical corticosteroid eye drops; monitor for additive effects on intra‑ocular pressure.
• Use alongside antihistamine eye drops; assess for overlapping ocular side effects.
• Co‑administration with systemic antihistamines; observe for any unexpected systemic reactions.
• Co‑administration with systemic immunosuppressants; monitor for any changes in ocular healing.
• Combining with other ocular lubricants; evaluate for cumulative preservative load.